Logo image of MCF

CONTANGO OIL & GAS (MCF) Stock Fundamental Analysis

NYSEARCA:MCF - NYSE Arca - Common Stock

3.22  +0.11 (+3.54%)

After market: 3.22 0 (0%)

Fundamental Rating

2

Overall MCF gets a fundamental rating of 2 out of 10. We evaluated MCF against 210 industry peers in the Oil, Gas & Consumable Fuels industry. MCF has a bad profitability rating. Also its financial health evaluation is rather negative. MCF has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year MCF has reported negative net income.
MCF Yearly Net Income VS EBIT VS OCF VS FCFMCF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 0 -100M -200M -300M

1.2 Ratios

Industry RankSector Rank
ROA -13.5%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MCF Yearly ROA, ROE, ROICMCF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 -200 -400 -600 -800 -1K

1.3 Margins

Industry RankSector Rank
OM 26.03%
PM (TTM) -28.38%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MCF Yearly Profit, Operating, Gross MarginsMCF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 0 -100 -200

More info and screens

0

2. Health

2.1 Basic Checks

Compared to 1 year ago, MCF has more shares outstanding
Compared to 1 year ago, MCF has an improved debt to assets ratio.
MCF Yearly Shares OutstandingMCF Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 50M 100M 150M
MCF Yearly Total Debt VS Total AssetsMCF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 100M 200M 300M 400M

2.2 Solvency

Based on the Altman-Z score of -0.21, we must say that MCF is in the distress zone and has some risk of bankruptcy.
A Debt/Equity ratio of 2.31 is on the high side and indicates that MCF has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 2.31
Debt/FCF N/A
Altman-Z -0.21
ROIC/WACCN/A
WACCN/A
MCF Yearly LT Debt VS Equity VS FCFMCF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 0 50M -50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 0.45 indicates that MCF may have some problems paying its short term obligations.
MCF has a Quick Ratio of 0.45. This is a bad value and indicates that MCF is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.45
Quick Ratio 0.44
MCF Yearly Current Assets VS Current LiabilitesMCF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 20M 40M 60M 80M 100M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 81.98% over the past year.
The Revenue has grown by 125.43% in the past year. This is a very strong growth!
MCF shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.62% yearly.
EPS 1Y (TTM)81.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-47.71%
Revenue 1Y (TTM)125.43%
Revenue growth 3Y12.86%
Revenue growth 5Y-0.62%
Sales Q2Q%218.77%

3.2 Future

MCF is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.46% yearly.
MCF is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 140.64% yearly.
EPS Next Y200%
EPS Next 2Y78.89%
EPS Next 3Y44.93%
EPS Next 5Y25.46%
Revenue Next Year1200.02%
Revenue Next 2Y460.68%
Revenue Next 3Y207.72%
Revenue Next 5Y140.64%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MCF Yearly Revenue VS EstimatesMCF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B
MCF Yearly EPS VS EstimatesMCF Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2 -4 -6 -8

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MCF. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 5.90 indicates a rather cheap valuation of MCF.
When comparing the Price/Forward Earnings ratio of MCF to the average of the S&P500 Index (22.70), we can say MCF is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 5.9
MCF Price Earnings VS Forward Price EarningsMCF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.09
MCF Per share dataMCF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MCF's earnings are expected to grow with 44.93% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y78.89%
EPS Next 3Y44.93%

More info and screens

0

5. Dividend

5.1 Amount

MCF does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CONTANGO OIL & GAS

NYSEARCA:MCF (12/7/2021, 8:08:43 PM)

After market: 3.22 0 (0%)

3.22

+0.11 (+3.54%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-15 2021-11-15
Earnings (Next)03-09 2022-03-09/bmo
Inst Owners0.01%
Inst Owner Change0%
Ins Owners1.31%
Ins Owner Change0%
Market Cap641.22M
Analysts45
Price Target5.1 (58.39%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 5.9
P/S 2.35
P/FCF N/A
P/OCF N/A
P/B 12.25
P/tB N/A
EV/EBITDA 7.09
EPS(TTM)-0.4
EYN/A
EPS(NY)0.55
Fwd EY16.94%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.37
BVpS0.26
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.5%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 26.03%
PM (TTM) -28.38%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 2.31
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.45
Quick Ratio 0.44
Altman-Z -0.21
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)81.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-47.71%
EPS Next Y200%
EPS Next 2Y78.89%
EPS Next 3Y44.93%
EPS Next 5Y25.46%
Revenue 1Y (TTM)125.43%
Revenue growth 3Y12.86%
Revenue growth 5Y-0.62%
Sales Q2Q%218.77%
Revenue Next Year1200.02%
Revenue Next 2Y460.68%
Revenue Next 3Y207.72%
Revenue Next 5Y140.64%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A